15A NCAC 13B .1201      DEFINITIONS

For the purpose of the Section, the following definitions apply:

(1)        "Blood and body fluids" means liquid blood, serum, plasma, other blood products, emulsified human tissue, spinal fluids, and pleural and peritoneal fluids.  Dialysates are not blood or body fluids under this definition.

(2)        "Generating facility" means any facility where medical waste first becomes a waste, including but not limited to any medical or dental facility, funeral home, laboratory, veterinary hospital and blood bank.

(3)        "Integrated medical facility" means one or more health service facilities as defined in G.S. 131E‑176(9b) that are:

(a)        located in a single county or two contiguous counties;

(b)        affiliated with a university medical school or that are under common ownership and control; and

(c)        serve a single service area.

(4)        "Medical waste" as defined in G.S. 130A‑290(18).

(5)        "Microbiological waste" means cultures and stocks of infectious agents, including but not limited to specimens from medical, pathological, pharmaceutical, research, commercial, and industrial laboratories.

(6)        "Microwave treatment" means treatment by microwave energy for sufficient time to render waste non-infectious.

(7)        "Off‑site" means any site which is not "on‑site".

(8)        "On‑site" means the same or geographically contiguous property which may be divided by public or private right‑of‑way.

(9)        "Pathological waste" means human tissues, organs and body parts; and the carcasses and body parts of all animals that were known to have been exposed to pathogens that are potentially dangerous to humans during research, were used in the production of biologicals or in vivo testing of pharmaceuticals, or that died with a known or suspected disease transmissible to humans.

(10)      "Regulated Medical Waste" means blood and body fluids in individual containers in volumes greater than 20 ml, microbiological waste, and pathological waste that have not been treated pursuant to Rule .1207 of this Section.

(11)      "Sharps" means and includes needles, syringes with attached needles, capillary tubes, slides and cover slips, and scalpel blades.

(12)      "Treatment" as defined in G.S. 130A‑309.26(a)(2).


History Note:        Authority G.S. 130A‑309.26;

Eff. October 1, 1990;

Amended Eff. April 1, 1993.